GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (ASX:PME) » Definitions » Median PS Value

Pro Medicus (ASX:PME) Median PS Value : A$34.76 (As of May. 01, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pro Medicus Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Pro Medicus's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.358. Pro Medicus's 10-Year median PS Ratio is 25.5965. Therefore, the Median PS Value for today is A$34.76.

As of today (2024-05-01), Pro Medicus's share price is A$109.25. Pro Medicus's Median PS Value is A$34.76. Therefore, Pro Medicus's Price to Median PS Value for today is 3.14.

The historical rank and industry rank for Pro Medicus's Median PS Value or its related term are showing as below:

ASX:PME' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.77   Med: 2.3   Max: 6.71
Current: 3.14

During the past 13 years, the highest Price to Median PS Value of Pro Medicus was 6.71. The lowest was 0.77. And the median was 2.30.

ASX:PME's Price-to-Median-PS-Value is ranked worse than
98.73% of 236 companies
in the Healthcare Providers & Services industry
Industry Median: 0.73 vs ASX:PME: 3.14

Pro Medicus Median PS Value Historical Data

The historical data trend for Pro Medicus's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus Median PS Value Chart

Pro Medicus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.77 8.31 12.47 21.69 34.76

Pro Medicus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 21.69 - 34.76 -

Competitive Comparison of Pro Medicus's Median PS Value

For the Health Information Services subindustry, Pro Medicus's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro Medicus's Price-to-Median-PS-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Pro Medicus's Price-to-Median-PS-Value falls into.



Pro Medicus Median PS Value Calculation

Pro Medicus's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=1.358*25.5965
=34.76

10-Year Median PS Ratio is 25.5965.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pro Medicus's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.358.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro Medicus  (ASX:PME) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Pro Medicus's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=109.25/34.76
=3.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro Medicus Median PS Value Related Terms

Thank you for viewing the detailed overview of Pro Medicus's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro Medicus (ASX:PME) Business Description

Traded in Other Exchanges
Address
450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.